Meta Platforms and Johnson & Johnson Outperform in Turbulent Market
Investors narrowly avoided a prolonged stock market downturn this year, with April's brief bear market sparking fears over tariff impacts. The recovery since has been sharp—mirrored in portfolios anchored by resilient dividend stocks.
Meta Platforms (META) defied expectations with a 22% revenue surge to $47.5 billion in Q2, while net income leapt 36%. Its AI-driven engagement algorithms and ad targeting efficiencies proved transformative. Though not primarily held for dividends, the tech giant's performance underscores how growth and yield can coexist.
Johnson & Johnson (JNJ) provided similar stability, leveraging its healthcare diversification to weather volatility. Both stocks exemplify the defensive appeal of cash-generating giants during uncertain periods—a lesson underscored by 2025's market whipsaw.
